FOLH1 and neoplasm: In addition, all anti-PSMA BsAb-armed T cells and OKT3-T cells did not attack PC-3 cells (Additional file 6: Movie 6, Additional file 7: Movie 7, Additional file 8: Movie 8, Additional file 9: Movie 9, Additional file 10: Movie 10, Additional file 11: figure S6), indicating that anti-PSMA BsAb-armed T cells have high tumor-killing specificity and excellent safety.